Hybrid
Biosynthesis by Targeted (Table 1) . It is suggested that the M7A21 strain is also able to attach mycinose at C-21 carbon on 5-O-mycaminosyltylonolide derivatives, which have structural differences from mycinamicin at the C-2, C-3 and C-12 positions of aglycone. Antibiotic activity of 19-deformyl-12,13-epoxydesmycosin (9) against Micrococcus luteus was almost the same level as that of compound 8 in paper disk diffusion assay (data not shown).
As the starting material for the biosynthesis of 19-deformyldesmycosin analogues, we prepared 19-deformyl-5-O-mycaminosyltylonolide (7) by organic synthesis.
19-Deformyldesmycosin (8) was derived from intact incorporation of compound 7 by the genetically manipulated mutant strain M. griseorubida M7A21.
Moreover, compound 9 was also detected in the HPLC chromatography as a minor component, which was Protomycinolide IV (1) was obtained by fermentation using M. griseorubida A11725 wild strain,2) mycinamicin VII (4) was prepared by mild acidic hydrolysis of mycimamicin IV,3) as described in previous papers. It is well known in the production of desmycosin (6) Desmycosin (6) 19-Deformyl-5-O-mycaminosyltylonolide (7) 19-Deformyldesmycosin (8) 19-Deformyl-12,13-epoxydesmycosin (9) The hydroxylation of mycinamicin IV at position 14 to mycinamicin V and the epoxidation of mycinamicin IV to mycinamicin II (4) are the final steps in the pathway to convert protomycinolide IV (1) to mycinamicin II (4)9) which is catalyzed by the cytochrome P450 oxidase Preparation of 19-Deformyl-5-O-maycaminosyltylonolide (7) 5-O-mycaminosyl-tylonolide (5, 607mg, 1.0mmol) and (Ph3P)3RhCl (1.03g, 1.1mmol) were dissolved in 20ml of dry benzene and refluxed for 5 hours under an argon atmosphere. The reaction mixture was evaporated and washed with acetone, then the resulting yellow precipitate was filtered off and the filtrate was evaporated in vacuo.
The residue was dissolved in 5ml of benzene and extracted extracts were combined and adjusted to pH 9 by adding
The organic solution was dried over anhydrous Na2SO4
and concentrated in vacuo to afford 19-deformyl-5-Omycaminosyl-tylonolide (10, 440mg) of white powder.14)
Preparation of 19-Deformyl-12,13-epoxydesmycosin
The retention time on HPLC and molecular weight of the bioconversion product 9 was identical with the synthetic compound 9, which was prepared with the following synthetic method. For structural elucidation and antibiotic activity test, the synthetic compound 9 was used.
To a stirred solution of 100mg (0. 
